Kempen Capital Management N.V. Pfizer Inc Transaction History

Kempen Capital Management N.V.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $62,107 - $75,345	-2,062 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $570,273 - $647,187	-17,323 Reduced 89.36%	2,062 $81,000
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $132,429 - $171,721	-4,076 Reduced 17.37%	19,385 $697,000
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $295,876 - $332,201	-8,001 Reduced 25.43%	23,461 $1.02 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $1.18 Million - $1.3 Million	31,462 New	31,462 $1.34 Million

3,239

3.6B

77.1M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Kempen Capital Management N.V., based on Form 13F filings with the SEC.

Stay updated on Kempen Capital Management N.V. with notifications on news.